694 related articles for article (PubMed ID: 25490097)
1. Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment.
Liu HL; Huang CY; Chen JY; Wang HY; Chen PY; Wei KC
PLoS One; 2014; 9(12):e114311. PubMed ID: 25490097
[TBL] [Abstract][Full Text] [Related]
2. Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study.
Wei KC; Chu PC; Wang HY; Huang CY; Chen PY; Tsai HC; Lu YJ; Lee PY; Tseng IC; Feng LY; Hsu PW; Yen TC; Liu HL
PLoS One; 2013; 8(3):e58995. PubMed ID: 23527068
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment.
Fan CH; Ting CY; Liu HL; Huang CY; Hsieh HY; Yen TC; Wei KC; Yeh CK
Biomaterials; 2013 Mar; 34(8):2142-55. PubMed ID: 23246066
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-induced opening of the blood-brain barrier to enhance temozolomide and irinotecan delivery: an experimental study in rabbits.
Beccaria K; Canney M; Goldwirt L; Fernandez C; Piquet J; Perier MC; Lafon C; Chapelon JY; Carpentier A
J Neurosurg; 2016 Jun; 124(6):1602-10. PubMed ID: 26566207
[TBL] [Abstract][Full Text] [Related]
5. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
[TBL] [Abstract][Full Text] [Related]
6. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.
Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N
Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014
[TBL] [Abstract][Full Text] [Related]
7. Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model.
Grossman R; Tyler B; Rudek MA; Kim E; Zadnik P; Khan U; Blakeley JO; Pathak AP; Brem H
Cancer Chemother Pharmacol; 2013 Jul; 72(1):93-100. PubMed ID: 23649683
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
9. Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.
Liu HL; Yang HW; Hua MY; Wei KC
Neurosurg Focus; 2012 Jan; 32(1):E4. PubMed ID: 22208897
[TBL] [Abstract][Full Text] [Related]
10. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
11. Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood-brain barrier opening and brain drug delivery.
Chai WY; Chu PC; Tsai MY; Lin YC; Wang JJ; Wei KC; Wai YY; Liu HL
J Control Release; 2014 Oct; 192():1-9. PubMed ID: 24969355
[TBL] [Abstract][Full Text] [Related]
12. Drug-loaded bubbles with matched focused ultrasound excitation for concurrent blood-brain barrier opening and brain-tumor drug delivery.
Fan CH; Ting CY; Chang YC; Wei KC; Liu HL; Yeh CK
Acta Biomater; 2015 Mar; 15():89-101. PubMed ID: 25575854
[TBL] [Abstract][Full Text] [Related]
13. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts.
Shen Y; Pi Z; Yan F; Yeh CK; Zeng X; Diao X; Hu Y; Chen S; Chen X; Zheng H
Int J Nanomedicine; 2017; 12():5613-5629. PubMed ID: 28848341
[TBL] [Abstract][Full Text] [Related]
14. Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study.
Chen PY; Hsieh HY; Huang CY; Lin CY; Wei KC; Liu HL
J Transl Med; 2015; 13():93. PubMed ID: 25784614
[TBL] [Abstract][Full Text] [Related]
15. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.
Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X
Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865
[TBL] [Abstract][Full Text] [Related]
16. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy.
Lamsam L; Johnson E; Connolly ID; Wintermark M; Hayden Gephart M
Neurosurg Focus; 2018 Feb; 44(2):E10. PubMed ID: 29385922
[TBL] [Abstract][Full Text] [Related]
17. Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas.
Minea RO; Duc TC; Swenson SD; Cho HY; Huang M; Hartman H; Hofman FM; Schönthal AH; Chen TC
PLoS One; 2020; 15(9):e0238238. PubMed ID: 32881880
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells.
Hu J; Wang J; Wang G; Yao Z; Dang X
Int J Mol Med; 2016 Mar; 37(3):690-702. PubMed ID: 26782731
[TBL] [Abstract][Full Text] [Related]
19. Delivery of DNA octahedra enhanced by focused ultrasound with microbubbles for glioma therapy.
Shen Y; Hu M; Li W; Chen Y; Xu Y; Sun L; Liu D; Chen S; Gu Y; Ma Y; Chen X
J Control Release; 2022 Oct; 350():158-174. PubMed ID: 35981634
[TBL] [Abstract][Full Text] [Related]
20. Image-guided chemotherapy with specifically tuned blood brain barrier permeability in glioma margins.
Gao X; Yue Q; Liu Y; Fan D; Fan K; Li S; Qian J; Han L; Fang F; Xu F; Geng D; Chen L; Zhou X; Mao Y; Li C
Theranostics; 2018; 8(11):3126-3137. PubMed ID: 29896307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
